Mittin intervention to improve contraceptive side effect counseling and follow-up in Addis Ababa
Official title: Cluster Randomized Controlled Trial of the "Mittin" Intervention in Addis Ababa, Ethiopia
Run by University of California, San Francisco · NCT07301281 · Data updated 2026-11-12
Aims to see if the Mittin program helps women who use hormonal methods or copper IUDs in Addis Ababa better manage their contraception according to their preferences.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 15 Years to 49 Years |
| Sex | Women only |
| Enrollment | 2715 (estimated) |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 1 site (Addis Ababa) |
| Status | Recruiting |
| Started | February 23, 2026 |
| Main results expected | June 2027 |
| Study ends | June 2027 |
| Registry record updated | July 23, 2026 |
| Trial ID | NCT07301281 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 15-49 in Addis Ababa who started or continued a hormonal method or copper IUD and are willing to provide contact information for follow-up.
✕Probably not a fit
Individuals not planning to stay in Addis Ababa for eight months or who cannot verbally communicate or provide consent may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional trial tests whether the Mittin program, added to standard contraception services, helps women aged 15-49 in Addis Ababa align their contraceptive choices with their preferences and improve satisfaction. Participants are randomized by site to receive either standard care or enhanced Mittin services, with surveys at enrollment, 4 months, and 8 months to gauge outcomes. The study is conducted at public health centers in Addis Ababa and is led by UCSF with Ethiopian collaborators and funders. The objective is to determine if Mittin improves preference-aligned fertility management and continued method use. No phase information is provided for this study.
Why it matters
Potential benefit: If successful, Mittin could help women choose and continue contraception that matches their preferences and reduces side-effect concerns.
How similar studies have gone: Previous studies in contraceptive counseling and follow-up show potential benefits of enhanced patient-centered support, but Mittin’s specific approach is novel in this setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Woman * Started or continued using hormonal contraceptive method or copper IUD on day of recruitment * Ages 15-49 years * Willing to provide phone number and receive follow-up phone call Exclusion Criteria: * Not planning to live in Addis Ababa for the next eight months * Can not verbally communicate * Not willing to provide consent for the study
Where it's running
-
St. Paul's Hospital Millennium Medical College
Addis Ababa, Ethiopia Recruiting
Study contacts
- Principal investigator: Kelsey Holt, ScD — University of California, San Francisco
- Study coordinator: Kelsey Holt, ScD
- Email: kelsey.holt@ucsf.edu
- Phone: 617-455-2693
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pain-relief medicines after tooth extractions: dipyrone vs paracetamol in adults
This study tests whether dipyrone or paracetamol, used for pain after dental extractions, have different effects on blood counts and safety in healthy adults.
-
Effectiveness of the Natural Cycles birth control app
This study will test how well the Natural Cycles app prevents pregnancy over one year in sexually active women aged 18 to 35 with no known infertility.
-
Female Reproductive Health in the Canadian Armed Forces: Understanding Issues from Contraception to Pelvic Floor Dysfunction
This observational study looks at reproductive health among women in the Canadian Armed Forces to see how contraception, pregnancy outcomes, infertility, pelvic floor issues, and related factors affect service members and veterans.
-
Long-acting HIV PrEP and contraception PK study in AGYW
This study tests how long-acting cabotegravir for PrEP interacts with hormonal contraception in young women.
-
Vasectomy: Right for Me? — a web-based decision aid
A web-based decision aid helps men think clearly about vasectomy and other birth control options to see if it fits their goals.
-
Contraceptive patch designed to stop ovulation
This trial tests whether a norelgestromin transdermal patch can keep ovulation suppressed for 84 days even when users make intentional application mistakes, in healthy women aged 18–35.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.